Scientific Digital Imaging appoints Isabel Napper to its Board as Non-Executive Director

– UK, Cambridge – Scientific Digital Imaging plc (AIM:SDI), the AIM quoted group focused on the design and manufacture of scientific and technology products for use by the life science, healthcare, astronomy, consumer manufacturing and art conservation markets, announces that, Jeremy Gibbs, Non-Executive Director, will be stepping down from the Board on 30 April 2017, having served on the Board for over 8 years after a long association with a subsidiary company.

In addition, the Company is pleased to announce the appointment of Isabel Napper as a Non-Executive Director with immediate effect.

Isabel has more than 25 years’ experience in advising clients in the technology and healthcare/life science areas, both public and private sector, leading on business development and managing regulatory issues, governance, risk and strategic change. Isabel was previously a Partner at the law firm Mills & Reeve where she acted as legal adviser and company secretary to a number of boards.

Ken Ford, Chairman of SDI, commented: “On behalf of the Board, I would like to thank Jeremy for his valuable contribution to SDI over the last two decades. We wish him well for the future. We are pleased to welcome Isabel Napper to the Board. Isabel brings a wealth of experience and knowledge and this will be a valuable addition for us in the Company’s future development.”

About SDI:

Scientific Digital Imaging plc designs and manufactures scientific and technology products for use in applications including life sciences, healthcare, astronomy, consumer manufacturing and art conservation. SDI intends to continue to grow through its own technology advancements as well as strategic, complementary acquisitions.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>